These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3358102)

  • 21. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Calvet L
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro susceptibility of atypical mycobacteria to Cephem and other antibiotics].
    Sakurai N
    Kekkaku; 1983 Jun; 58(6):355-62. PubMed ID: 6620790
    [No Abstract]   [Full Text] [Related]  

  • 23. [Resistance to antibiotics of mycobacteria of the Province of Cadiz].
    del Rey Calero J; Casal Roman M
    Rev Sanid Hig Publica (Madr); 1971 Jan; 45(1):73-114. PubMed ID: 5006012
    [No Abstract]   [Full Text] [Related]  

  • 24. [Sensitivity of anaerobic bacteria: when and how].
    Borobio MV
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):196-9. PubMed ID: 1863617
    [No Abstract]   [Full Text] [Related]  

  • 25. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro activities of gemifloxacin, other quinolones, and nonquinolone antimicrobials against obligately anaerobic bacteria.
    Kleinkauf N; Ackermann G; Schaumann R; Rodloff AC
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1896-9. PubMed ID: 11353648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative investigation in vitro of the sensibility of atypical mycobacteria to cycloserine and to other antibacterial substances.
    Gernez-Rieux C; Devulder B
    Scand J Respir Dis Suppl; 1970; 71():22-34. PubMed ID: 5271991
    [No Abstract]   [Full Text] [Related]  

  • 28. Susceptibility testing of anaerobic bacteria.
    Citron D
    Am J Med Technol; 1983 Nov; 49(11):769-72. PubMed ID: 6316785
    [No Abstract]   [Full Text] [Related]  

  • 29. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms.
    Jorgensen JH; Ferraro MJ
    Clin Infect Dis; 2000 May; 30(5):799-808. PubMed ID: 10816150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
    Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
    Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic sensitivity testing of anaerobes.
    Phillips I
    Scand J Infect Dis Suppl; 1982; 35():31-6. PubMed ID: 6820186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaerobic infections--the most important antimicrobial drugs and their clinical profile.
    Solberg CO
    Scand J Gastroenterol Suppl; 1983; 85():14-22. PubMed ID: 6353550
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antimicrobial drug therapy and microbial sensitivity tests--antibiotics and microbial sensitivity tests].
    Kanno H
    Rinsho Byori; 1997 Jul; Suppl 105():174-81. PubMed ID: 9379537
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies of the resistance of mycobacteria].
    Savov N
    Vet Med Nauki; 1973; 10(2):39-49. PubMed ID: 4213759
    [No Abstract]   [Full Text] [Related]  

  • 35. Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics".
    Bergan T; Bruun JN; Digranes A; Lingaas E; Melby KK; Sander J
    Scand J Infect Dis Suppl; 1997; 103():1-36. PubMed ID: 9253777
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sensitivity of anaerobic bacteria to antibiotics: experience at Hôpital Saint-Luc].
    Lamothe F; Bourgault AM; Turgeon P; Vincelette J; Gaudreau C; Turgeon F
    Union Med Can; 1984 Jun; 113(6):485-8. PubMed ID: 6385431
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro antibacterial activity of macrolides and other antibiotics against anaerobic bacteria.
    Ravizzola G; Pirali F; Colombrita D; Pollara P; Abeni D; Flamminio G; Turano A
    J Chemother; 1989 Jul; 1(4 Suppl):194-5. PubMed ID: 16312365
    [No Abstract]   [Full Text] [Related]  

  • 38. Study of fungal and bacterial infections of the diabetic foot.
    Chincholikar DA; Pal RB
    Indian J Pathol Microbiol; 2002 Jan; 45(1):15-22. PubMed ID: 12593559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing.
    Hecht DW
    Anaerobe; 2006 Jun; 12(3):115-21. PubMed ID: 16765857
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
    Rokosz A; Sawicka-Grzelak A; Kot K; Meszaros J; Łuczak M
    Med Dosw Mikrobiol; 2001; 53(2):167-75. PubMed ID: 11757426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.